Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density
Authors
Keywords
-
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 138, Issue 4, Pages 647-655
Publisher
Springer Nature
Online
2012-01-07
DOI
10.1007/s00432-011-1099-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer
- (2011) Coya Tapia et al. HUMAN PATHOLOGY
- Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma
- (2011) Xiao-han Li et al. ORAL ONCOLOGY
- Downregulated Expression of Inhibitor of Growth 4 (ING4) in Advanced Colorectal Cancers: A Non-Randomized Experimental Study
- (2011) Qi You et al. PATHOLOGY & ONCOLOGY RESEARCH
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Functional impact of cancer-associated mutations in the tumor suppressor protein ING4
- (2010) Alberto Moreno et al. CARCINOGENESIS
- Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
- (2010) Patricia Pautier et al. GYNECOLOGIC ONCOLOGY
- Down-regulation of ING4 is associated with initiation and progression of lung cancer
- (2010) Qiu-shi Wang et al. HISTOPATHOLOGY
- Lymph Node Metastasis in Grossly Apparent Stages I and II Epithelial Ovarian Cancer
- (2010) Hiroyuki Nomura et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular Carcinoma
- (2009) F. Fang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
- (2009) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
- (2009) Russell J. Schilder et al. GYNECOLOGIC ONCOLOGY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced expression and novel splice variants ofING4in human gastric adenocarcinoma
- (2009) Ming Li et al. JOURNAL OF PATHOLOGY
- Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis
- (2008) Yufeng Xie et al. CANCER LETTERS
- Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
- (2008) Russell J. Schilder et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now